| Metric | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 2.4M -79.1% | 11.4M -47.4% | 21.6M +544.9% | 3.4M +7.8% | 3.1M |
| R&D | 22.0K -38.9% | 36.0K +20.0% | 30.0K -34.8% | 46.0K +360.0% | 10.0K |
| SG&A | 2.4M -19.0% | 2.9M +6.4% | 2.7M -17.2% | 3.3M +6.7% | 3.1M |
| Operating Income | -2377000 +79.1% | -11361000 +47.4% | -21610000 -544.9% | -3351000 -7.8% | -3108000 |
| EBITDA | -2377000 +79.1% | -11361000 +47.4% | -21610000 -544.9% | -3351000 -7.8% | -3108000 |
| Net Income | 16.0M +223.1% | -13018000 +45.1% | -23694000 +23.1% | -30799000 -746.4% | -3639000 |
| EPS (Basic) | $0.48 +233.3% | $-0.36 +45.5% | $-0.66 +19.5% | $-0.82 -583.3% | $-0.12 |
| EPS (Diluted) | $0.48 +233.3% | $-0.36 +45.5% | $-0.66 +19.5% | $-0.82 -583.3% | $-0.12 |
| Shares (Diluted) | 33.2M -7.0% | 35.7M -0.1% | 35.7M -4.4% | 37.4M +26.8% | 29.5M |